Role of Th17 Cell and Autoimmunity in Chronic Obstructive Pulmonary Disease

키워드

참고문헌 (53)

1. Hogg JC, "The pathology of chronic obstructive pulmonary disease", Annu Rev Pathol, 4, pp.435~459 (2009)
2. Mathers CD, "Projections of global mortality and burden of disease from 2002 to 2030", PLoS Med, 3, pp.E442~ (2006)
3. Fletcher C, "The natural history of chronic airflow obstruction", Br Med J, 1, pp.1645~1648 (1977)
4. Ind PW, "COPD disease progression and airway inflammation: uncoupled by smoking cessation", Eur Respir J, 26, pp.764~766 (2005)
5. Simmons MS, "Smoking reduction and the rate of decline in FEV(1): results from the Lung Health Study", Eur Respir J, 25, pp.1011~1017 (2005)
6. Chung KF, "Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction", Eur Respir J, 31, pp.1334~1356 (2008)
7. Sharafkhaneh A, "Pathogenesis of emphysema: from the bench to the bedside", Proc Am Thorac Soc, 5, pp.475~477 (2008)
8. Taraseviciene-Stewart L, "Molecular pathogenesis of emphysema", J Clin Invest, 118, pp.394~402 (2008)
9. Tuder RM, "State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective", Proc Am Thorac Soc, 3, pp.503~510 (2006)
10. Motz GT, "Persistence of lung CD8 T cell oligoclonal expansions upon smoking cessation in a mouse model of cigarette smoke-induced emphysema", J Immunol, 181, pp.8036~8043 (2008)
11. Motz GT, "Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-", - mice, 2010, pp.181, 1223~1233
12. Sullivan AK, "Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema", Am J Respir Crit Care Med, 172, pp.590~596 (2005)
13. Lee SH, "Antielastin autoimmunity in tobacco smoking-induced emphysema", Nat Med, 13, pp.567~569 (2007)
14. Hogg JC, "The nature of small-airway obstruction in chronic obstructive pulmonary disease", N Engl J Med, 350, pp.2645~2653 (2004)
15. Baraldo S, "Neutrophilic infiltration within the airway smooth muscle in patients with COPD", Thorax, 59, pp.308~312 (2004)
16. Keatings VM, "Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma", Am J Respir Crit Care Med, 153, pp.530~534 (1996)
17. Traves SL, "Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD", Thorax, 57, pp.590~595 (2002)
18. Shapiro SD, "Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice", Am J Pathol, 163, pp.2329~2335 (2003)
19. Voynow JA, "Neutrophil elastase increases MUC5AC mRNA and protein expression in respiratory epithelial cells", Am J Physiol, 276, pp.L835~L843 (1999)
20. Barnes PJ, "Alveolar macrophages as orchestrators of COPD", COPD, 1, pp.59~70 (2004)
21. Churg A, "Proteases and emphysema", Curr Opin Pulm Med, 11, pp.153~159 (2005)
22. Russell RE, "Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases", Am J Physiol Lung Cell Mol Physiol, 283, pp.L867~L873 (2002)
23. Finlay GA, "Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients", Thorax, 52, pp.502~506 (1997)
24. Hautamaki RD, "Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice", Science, 277, pp.2002~2004 (1997)
25. Grumelli S, "An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema", PLoS Med, 1, pp.e8~ (2004)
26. Fujita M, "Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension", Am J Physiol Lung Cell Mol Physiol, 280, pp.L39~L49 (2001)
27. Aaron SD, "Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 163, pp.349~355 (2001)
28. Dentener MA, "Effect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot study", Respiration, 76, pp.275~282 (2008)
29. Rennard SI, "COPD Investigators: The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 175, pp.926~934 (2007)
30. Sapey E, "Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD", J Clin Immunol, 29, pp.508~516 (2009)
31. Bhowmik A, "Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations", Thorax, 55, pp.114~120 (2000)
32. Calabrese F, "novel proinflammatory cytokine in chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 178, pp.894~901 (2008)
33. Miossec P, "Interleukin-17 and type 17 helper T cells", N Engl J Med, 361, pp.888~898 (2009)
34. Louten J, "Development and function of TH17 cells in health and disease", J Allergy Clin Immunol, 123, pp.1004~1011 (2009)
35. Jones CE, "Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocytecolony-stimulating factor by human airway epithelial cells", Am J Respir Cell Mol Biol, 26, pp.748~753 (2002)
36. Kao CY, "Up-regulation of CC chemokine ligand 20 expression in human airway epithelium by IL-17 through a JAK-independent but MEK", NF-kappaB-dependent signaling pathway, 2005, pp.175, 6676~6685
37. Chen Y, "Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine", autocrine loop, 2003, pp.278, 17036~17043
38. Park H, "A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17", Nat Immunol, 6, pp.1133~1141 (2005)
39. Harrison OJ, "Airway infiltration of CD4+ CCR6+ Th17 type cells associated with chronic cigarette smoke induced airspace enlargement", Immunol Lett, 121, pp.13~21 (2008)
40. Barczyk A, "Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine", Respir Med, 97, pp.726~733 (2003)
41. Ikeuchi H, "Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine", Arthritis Rheum, 52, pp.1037~1046 (2005)
42. Wolk K, "The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis", Eur J Immunol, 39, pp.3570~3581 (2009)
43. Aujla SJ, "IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia", Nat Med, 14, pp.275~281 (2008)
44. Di Stefano A, "T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients", Clin Exp Immunol, 157, pp.316~324 (2009)
45. Sonnenberg GF, "Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A", J Exp Med, 207, pp.1293~1305 (2010)
46. Cua DJ, "Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain", Nature, 421, pp.744~748 (2003)
47. Murphy CA, "Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation", J Exp Med, 198, pp.1951~1957 (2003)
48. Langrish CL, "IL-23 drives a pathogenic T cell population that induces autoimmune inflammation", J Exp Med, 201, pp.233~240 (2005)
49. Voelkel N, "Emphysema: an autoimmune vascular disease?", Proc Am Thorac Soc, 2, pp.23~25 (2005)
50. Agustí A, "Hypothesis: does COPD have an autoimmune component?", Thorax, 58, pp.832~834 (2003)
51. Shan M, "Lung myeloid dendritic cells coordinately induce TH1 and TH17 responses in human emphysema", Science Translational Medicine, 1, pp.4~10 (2009)
52. Cottin V, "Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema", Eur Respir J, 33, pp.219~221 (2009)
53. Greene CM, "Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease", Am J Respir Crit Care Med, 181, pp.31~35 (2010)

관련 논문AI추천